• About PRIME
  • Advertise With Us
  • Contact Us
Advertisement
PRIME Journal
  • Home
  • Digital Issue
  • Categories
    • Energy Based Devices
    • Minimally Invasive
    • Skincare
    • Injectables
    • Dermatology
    • Anti-ageing
    • Body Contouring
    • Invasive treatments
  • Features
    • Case Study
    • PRIME People
    • Company Profile
    • Industry Analysis
    • Sponsored Features
  • News
  • Sign Up

Select Page

PRIME March/April 2024 issue

Digital Magazine, News

Share:

PreviousThe FACE Conference Gets a Facelift for the 2024 edition
NextThe Beauty Triangle Launch New Event in Dubai

Related Posts

New clinical approach to melasma treatment

New clinical approach to melasma treatment

March 29, 2019

Pure Retinol 0.5 and Retinol 1.0 – New improved formulation

Pure Retinol 0.5 and Retinol 1.0 – New improved formulation

June 13, 2018

Doctors warn against do-it-yourself injections trending during pandemic

Doctors warn against do-it-yourself injections trending during pandemic

June 2, 2021

U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite

U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite

July 7, 2020

Search

Login Status

Forgot?  Register

Sept/Oct 2026 Issue

Advertisement

Upcoming Events

No events are found.

All events

Categories

  • Injectables
  • Dermatology
  • Anti-ageing
  • Body Contouring
  • Invasive treatments
  • Case Study
  • Practice Management
  • Sponsored
  • Industry Insider
  • Company Profile
  • PRIME People
  • Meeting reviews
  • Commentary

Designed by Elegant Themes | Powered by WordPress

  • Contact Us
  • Editorial Board
  • Terms & Conditions
  • Privacy Policy